The device acts on the supraorbital nerve and supratrochlear nerve, the nerves that transmit migraine pain. The Food and Drug Administration (FDA) has cleared WAT Medical’s HeadaTerm 2 as an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results